Market Overview

Scar Therapeutics | A Drug Pipeline Analysis Report 2018 | Technavio

Share:

Technavio has announced their latest pipeline analysis report on the
drug pipeline for scar
therapeutics
. The report includes a detailed analysis of the
pipeline molecules under investigation within the defined data
collection period to treat scars.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180809005710/en/

Technavio has published a new report on the drug development pipeline for scar therapeutics, includi ...

Technavio has published a new report on the drug development pipeline for scar therapeutics, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market.

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

Scars: Market overview

Scars are the changes in the physical architecture of the skin. A scar
occurs on the skin due to the damage in the layer of the skin, the
dermis. Scars can also occur due to the healing process of skin tissues,
and severity of a scar depends upon the nature of the wound. The
symptoms of scars include an itchy patch of skin, a lumpy or ridged area
of skin that is usually raised, and formation of excessive scar tissues
in the region of injury. There are different types of scars which
includes keloid scars, hypertrophic scars, contracture scars, and acne
scars.

According to a senior market research analyst at Technavio, "In
dermatology, a scar is the area of tissue that replaces the normal skin
after an injury. The skin is in direct contact with the environment, and
there are high chances of developing sensations and irritations.
However, the appearances of scars differ from person to person,
depending upon the skin type, the location affected, and the type of
injury."

Scar therapeutics: Segmentation analysis

This pipeline analysis report segments the scar therapeutics market
based on therapies employed (monotherapy), RoA (intradermal, topical,
intradermal and topical, intramuscular, oral, parenteral, subcutaneous,
and subcutaneous and intradermal), therapeutic modality (RNA, small
molecule, peptide, protein, and stem cell), targets (CTGF, beta-catenin,
IL-1, IL-6, IL-8, and TNF alpha, lysyl oxidase (LOX), muscles, nrf2,
TGF- β, and TGF- β1 and COX-2), MoA (CTGF inhibitor, beta-catenin
modulator, IL-1, IL-6, IL-8, and TNF alpha inhibitor, LOX inhibitor,
blocking muscle contraction, Nrf2 activator, TGF- β inhibitor, and TGF-
β1 and COX-2 gene expression inhibitor), geographical segmentation (UK,
Dominican Republic, Honduras, Canada, and US) and recruitment status
(active, not recruiting, completed, not yet recruiting, and recruiting).
It provides an in-depth analysis of the prominent factors influencing
the market, including drivers, opportunities, trends, and
industry-specific challenges.

Based on the therapeutic modality, around 27% of the molecules that are
being investigated for the treatment of the scars are RNA. RNA is a
polymeric molecule essential in various biological roles such as the
coding, decoding, regulation, and expression of genes.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.

View Comments and Join the Discussion!